Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Progressie van leverfibrose na acute HCV-infectie bij hiv-positieve MSM
mrt 2019 | Hepatitis, HIV